DAVID ALDUNCIN: Open Payments
NPI 1841950698 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 6 payments from 4 companies in 2025. Trend: 2023 $25 · 2024 $285 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| Sanara MedTech Inc. | 2 | $195 |
| AstraZeneca Pharmaceuticals LP | 1 | $120 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
Products named: LOKELMA, CellerateRX, Biasurge, REXULTI, INGREZZA.
Industry payments across FL — which companies pay providers there.
